The phosphodiesterase inhibitor pentoxifylline reduces early side effects of interferon-beta 1b treatment in patients with multiple sclerosis

Neurology. 1996 Aug;47(2):604. doi: 10.1212/wnl.47.2.604.
No abstract available

MeSH terms

  • Humans
  • Interferon-beta / adverse effects*
  • Multiple Sclerosis / drug therapy*
  • Pentoxifylline / therapeutic use*

Substances

  • Interferon-beta
  • Pentoxifylline